Eichelbaum M, Ende M, Remberg G, Schomerus M, Dengler H J
Drug Metab Dispos. 1979 May-Jun;7(3):145-8.
The metabolism of DL-verapamil in man was studied after oral administration of an aqueous solution of DL-[14C]verapamil. Between 67 and 71% of the 14C administered was excreted in the urine within 5 days. Verapamil was extensively metabolized; only 3--4% of the dose was excreted in the urine as unchanged drug. Cleavage of the C--N--C bond by N-'dealkylation, preferentially at the C-atom belonging to the shorter side chain, was the main metabolic step. Verapamil and its N-dealkylated metabolites were further metabolized by O-demethylation. Inasmuch as approximately 10 times more of the metabolites formed from the tertiary amine verapamil are secondary amines than are primary amines, it would seem that N-dealkylation of this tertiary amine proceeds at a much higher rate than the N-dealkylation of the secondary amine metabolites to primary amine metabolites.
口服DL-[14C]维拉帕米水溶液后,对其在人体中的代谢情况进行了研究。给药的14C中有67%至71%在5天内随尿液排出。维拉帕米被广泛代谢;只有3%至4%的剂量以原形药物随尿液排出。通过N-去烷基化作用切断C-N-C键,优先在属于较短侧链的碳原子上进行,这是主要的代谢步骤。维拉帕米及其N-去烷基化代谢产物通过O-去甲基化进一步代谢。由于由叔胺维拉帕米形成的代谢产物中,仲胺比伯胺多大约10倍,因此看来这种叔胺的N-去烷基化速率比仲胺代谢产物向伯胺代谢产物的N-去烷基化速率高得多。